The role of telemedicine in the delivery of health care in the COVID‐19 pandemic

Impact of COVID‐19 pandemic on mental health of patients with inherited bleeding disorders in Germany

“…One of the major concerns of patients with IBD could be how to maintain access to treatment products and care within the haemophilia treatment centres (HTCs) during the corona crisis. 7,16,17 Home delivery of treatment products and supplies as well as telemedicine bring medical care to patients in order to avoid frequent hospital visits and reduce the transmission of COVID-19. 18,19 Since patients with IBD and any type of severity might be in- Up to now, few data are available on haemophilia patients related to COVID-19.…”

Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

“…In the circumstances of the COVID19 pandemic, the approval and refunding of tele/videoconsultations by the government was accelerated but for skin cancer treatment and follow-up teleconsultations are often suboptimal. 10,11 These recommendations were needed to take on a nationwide similar approach for the different indications in dermato-oncology; it was also a way to monitor replanning of postponed consultations since acceptable delay period was defined for different indications in dermato-oncology. Because of the fast changing situation, the introduction of the guidelines mentions that 'these recommendations could serve as a guidance and are based on a general weighing of pros/cons.…”

What COVID-19 can mean for people with hemophilia beyond the infection risk

“…Great advances in TM have always been achieved in times of crisis [18,19]. Although several groups had already used TM to monitor patients with bleeding diathesis before the COVID-19 outbreak, today it is essential to implement this technology quickly [20,21].…”

“…infusions administered, as well as serving as educational tools to promote adherence to treatment [18]. Another benefit of TM in this era is the use of mobile applications that allow us to obtain real-time information on the pharmaco-therapeutic management performed by patients.…”